Medical Equipment

Neuroendovascular Coil Market to Reach $1.83 Billion by 2029, Growing at a CAGR of 7.1%

November 17, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Market Value Is The Neuroendovascular Coil Industry Expected To Reach By 2029, Starting From 2025 Levels?

The market for neuroendovascular coils has experienced robust expansion lately; a valuation increase from $1.29 billion in 2024 to $1.39 billion projected for 2025 marks this, reflecting an 8.3% compound annual growth rate. This uptrend during the past period is largely due to the rising prevalence of neurovascular ailments, an expanding older demographic, advancements in diagnostic methods, the proliferation of neurointerventional centers, active educational and awareness campaigns, alongside favorable regulatory clearances and standards being established.

Anticipation surrounds the neuroendovascular coil sector, forecasting robust expansion ahead; by 2029, its market valuation is projected to reach $1.83 billion, reflecting a consistent annual increase measured at a 7.1% compound rate, a trajectory fueled by escalating instances of neurovascular conditions, the broadening of available neurointerventional procedures, an emphasis placed upon timely diagnostics and treatment initiation, the overall development of global medical facilities, increasing adoption of care models centered around the patient, and deepening cooperative efforts in worldwide scientific investigation. Key developments shaping this market going forward will encompass progressive innovations in coil detachment mechanisms, greater adoption rates for liquid embolic agents, the creation of coils possessing bioactive or fully resorbable material properties, the incorporation of coil systems featuring double-layered designs, and a heightened concentration on employing flow diverters as a method for managing aneurysms.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13495&type=smp

Which Industry Drivers Are Expected To Accelerate The Neuroendovascular Coil Market From 2025 To 2029?

The increasing incidence of conditions affecting the neurovasculature is poised to boost expansion within the market for neuroendovascular coils. Abnormalities in the vessels that supply the nervous system often result in neurological signs and adverse outcomes. These neuroendovascular coils serve as a treatment modality where they are introduced into the vasculature to occlude or stabilize irregular vessel formations, thereby lowering the likelihood of hemorrhage or related issues. To illustrate this impact, data released in November 2023 by Socialstyrelsen, a governmental body based in Sweden, indicated that approximately 26,800 strokes were recorded in 2022, affecting roughly 25,100 people; of those afflicted by stroke that year, mortality within the first day reached 12 percent, within 28 days stood at 23 percent, and within a full year, it accounted for 34 percent, thus establishing the rising frequency of neurovascular pathologies as a key factor stimulating the neuroendovascular coil market’s progression.

What Are The Major Segment Categories Driving The Neuroendovascular Coil Market Growth?

The neuroendovascular coilmarket covered in this report is segmented –

1) By Product Type: Guglielmi Detachable Coils (GDCs), Matrix Coils

2) By Indication: Ruptured Aneurysm, Unruptured Aneurysm

3) By Application: Tumor Surgery, Medical Teaching

4) By End User: Hospitals, Ambulatory Surgical Centers (ASCs), Stroke Centers, Other End Users

Subsegments:

1) By Guglielmi Detachable Coils (GDCs): Soft GDCs, Standard GDCs, Detachable GDCs With Various Configurations

2) By Matrix Coils: Soft Matrix Coils, Coated Matrix Coils, Detachable Matrix Coils, Flow Diverter Matrix Coils

How Are Trends Influencing The Neuroendovascular Coil Market?

Leading enterprises within the neuroendovascular coil sector are concentrating their efforts on innovating coils characterized by enhanced softness and distinctive geometries as a means to secure a greater market share. These specialized coil designs, including shapes like tetrahedrons, significantly benefit neuroendovascular interventions by conforming more effectively to the patient’s vascular structure during aneurysm treatment, thereby mitigating adverse events and fostering superior recovery profiles, particularly when dealing with intricate anatomical challenges. A concrete example comes from December 2022, when the US medical device manufacturer Stryker Corporation introduced the Target Tetra Detachable Coil; this device integrates a novel tetrahedral configuration and sophisticated pliability, engineered primarily for the management of diminutive aneurysms, offering dual benefits through a distinctive geometric structure that ensures secure placement in aneurysms with broad necks alongside a gentle, helically shaped terminus, presenting a paradoxical yet beneficial combination of robust shape retention and inherent softness ideal for smaller pathological formations.

Which Leading Players Are Enhancing Their Neuroendovascular Coil Market Presence Worldwide?

Major companies operating in the neuroendovascular coil market report are Cardinal Health Inc., Johnson & Johnson Services Inc., Medtronic PLC, Stryker Corporation, Boston Scientific Corporation, B. Braun Melsungen AG, Terumo Corporation, Kaneka Neurovascular USA, W.L. Gore & Associates Inc., Cook Group Incorporated, Merit Medical Systems Inc., MicroPort Scientific Corporation, Penumbra Inc., MicroVention Inc., Medikit Co. Ltd., Minnetronix Medical Inc., SurModics Inc., Galen Medical Group P.C, Balt USA LLC, Acandis GmbH, Rapid Medical Ltd., Allium Medical Solutions Ltd., Shape Memory Medical Inc., InnoCore Pharmaceuticals BV, Wuhan HNC Technology Co. Ltd., Neural Co. Ltd., Three Rivers Medical Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/neuroendovascular-coil-global-market-report

Which Global Regions Are Influencing The Competitive Landscape Of The Neuroendovascular Coil Market?

North America was the largest region in the neuroendovascular coil market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neuroendovascular coil market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Neuroendovascular Coil Market Report:

https://www.thebusinessresearchcompany.com/customise?id=13495&type=smp

Browse Through More Reports Similar to the Global Neuroendovascular Coil Market 2025, By The Business Research Company

Neuropathic Pain Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/neuropathic-pain-global-market-report

Neurotrophic Keratitis Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/neurotrophic-keratitis-treatment-global-market-report

Neurofibromatosis Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/neurofibromatosis-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795